Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2020 12:33 ET | Source: AB Science

Lettre aux partenaires d'AB Science concernant l’impact de la pandémie COVID-19 sur les études cliniques d’AB Science

Paris, 7 avril 2020, 18h15 Lettre à nos partenaires concernant l’impact de la pandémie COVID-19 sur lesétudes cliniques d’AB Science Chers partenaires, À l'heure actuelle, nous prévoyons que...
April 07, 2020 12:33 ET | Source: AB Science

Letter to AB Science stakeholders on COVID-19 pandemic impact on AB Science clinical studies

Paris, April 07, 2020, 6.15pm A letter to our stakeholders on COVID-19 pandemic impact on AB Science clinical studies Dear Stakeholders, At this time, we expect that the COVID-19 pandemic will have...
March 31, 2020 11:35 ET | Source: AB Science

AB Science annonce que la FDA autorise le recrutement de patients aux USA dans l’étude de phase 3 du masitinib dans la Sclérose Latérale Amyotrophique (SLA)

Paris, 31 mars 2020, 17h30 La FDA autorise le recrutement de patients aux USA dans l’étude dephase 3 du masitinib dans la Sclérose Latérale Amyotrophique (SLA) AB Science SA (NYSE Euronext –...
March 31, 2020 11:35 ET | Source: AB Science

AB Science announces that FDA clears masitinib IND in Amyotrophic Lateral Sclerosis (ALS), allowing U.S. patient enrollment to commence in Phase 3 study

Paris, March 31, 2020, 5.30pm FDA clears masitinib IND in Amyotrophic Lateral Sclerosis (ALS), allowing U.S. patient enrollment to commence in Phase 3 study AB Science SA (NYSE Euronext -...
March 13, 2020 02:32 ET | Source: AB Science

AB Science présentera les résultats de son étude de phase 3 dans l’asthme sévère à la conférence international 2020 de l'American Thoracic Society

Paris, 13 mars 2020, 7h30 AB Science présentera les résultats de son étude de phase 3 dans l’asthmesévère à la conférence international 2020 de l'American Thoracic Society Une présentation orale...
March 13, 2020 02:32 ET | Source: AB Science

AB Science will present results from its Phase 3 AB07015 study in severe asthma at the 2020 American Thoracic Society International Conference

Paris, March 13 2020, 7.30am AB Science to present results from its Phase 3 AB07015 study in severe asthma at the 2020 American Thoracic Society International Conference Platform presentation will...
March 12, 2020 17:11 ET | Source: AB Science

AB Science will present results from its Phase 3 AB07015 study in severe asthma at the 2020 American Thoracic Society International Conference

Paris, March 12 2020, 10pm AB Science to present results from its Phase 3 AB07015 study in severe asthma at the 2020 American Thoracic Society International Conference Platform presentation will be...
March 09, 2020 16:06 ET | Source: AB Science

AB Science fournit le résumé de la conférence web du 6 mars 2020 sur les formes progressives de la sclérose en plaques avec les principaux leaders d’opinion de cette maladie

Paris, 9 mars 2020, 21h Résumé de la conférence web avec les principaux leaders d’opinion autourdes résultats de la phase 2B/3 du masitinib dans les formes progressives de lasclérose en plaques AB...
March 09, 2020 16:06 ET | Source: AB Science

AB Science is providing a summary of the live webcast held on 06 March 2020 with key opinion leaders in progressive forms of multiple sclerosis

Paris, 09 March 2020, 9pm Summary of webcast with Key Opinion Leaders on masitinibPhase 2B/3 results in Progressive Forms of Multiple Sclerosis AB Science SA (NYSE Euronext - FR0010557264 - AB) is...
March 05, 2020 13:26 ET | Source: AB Science

AB Science will host a live webcast on masitinib in Progressive Forms of Multiple Sclerosis on Friday March 06, 2020

Paris, March 05, 2020, 6.30pm AB Science will host a live webcast on masitinib in Progressive Forms of Multiple Sclerosis on Friday March 06, 2020 AB Science SA (NYSE Euronext – FR0010557264 – AB)...